Patents by Inventor METASIGNAL THERAPEUTICS INC.

METASIGNAL THERAPEUTICS INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH
    Publication number: 20130190396
    Abstract: Therapeutic ureido-sulfonamide compositions having compounds with the formula R-Q-Ar—SO2NH2 are disclosed, which compounds selectively inhibit CAIX and CAXII, and which are effective to inhibit hypoxic tumor growth, suppress metastases, and impair and deplete cancer stem cells in mammals.
    Type: Application
    Filed: January 9, 2013
    Publication date: July 25, 2013
    Applicant: METASIGNAL THERAPEUTICS INC.
    Inventor: METASIGNAL THERAPEUTICS INC.